ARYA Sciences Acquisition Corp IV

ARYD

KYG316591083

Investment Holding Companies

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-25 pm EDT			5-day change	1st Jan Change
11.33 ^USD	-0.18%		+0.18%	+3.94%

Mar. 29	ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 08	ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	CI

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023

May 12, 2023 at 04:31 pm EDT

ARYA Sciences Acquisition Corp IV reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 0.160249 million compared to net loss of USD 0.211186 million a year ago.

Latest news about ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	Feb. 07	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding from ARYA Sciences Holdings IV	23-09-26	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV	23-06-01	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-06	CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	23-04-05	CI
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV	23-02-27	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.12 million in funding from ARYA Sciences Holdings IV	22-11-06	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-08	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-13	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-31	CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	22-03-30	CI
Amicus Therapeutics Loss Narrows, Revenue Rises in 2021; Terminates ARYA Sciences Combination Over Market Conditions	22-02-24	MT
Gene Therapy Business of Amicus Therapeutics, Inc. cancelled the acquisition of ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	22-02-22	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12	CI
ARYA Sciences Acquisition Corp IV Provides Earnings Guidance for the Year 2021	21-11-09	CI
Editas Medicine : Health Care Stocks Easing Slightly From Intra-Day Highs Near Close	21-09-29	MT
Adagio Therapeutics : Health Care Stocks Recovering From Tuesday Selloff	21-09-29	MT
Amicus Therapeutics : Arya Sciences Acquisition Corp to Create Genetic Medicine Company Caritas Therapeutics	21-09-29	MT
ARYA Sciences Acquisition Corp IV announced that it expects to receive $201.5 million in funding from a group of investors	21-09-28	CI
Gene Therapy Business of Amicus Therapeutics, Inc. entered into a non-binding agreement to acquire ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	21-09-28	CI

Chart ARYA Sciences Acquisition Corp IV

Duration

Period

More charts

Company Profile

ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
ARYA SCIENCES ACQUISITION CORP IV	+3.94%	89.82M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+137.37%	5.68B
SCREAMING EAGLE ACQUISITION CORP.	+1.89%	1.01B
CHURCHILL CAPITAL CORP VII	+2.19%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+25.27%	819M
ARES ACQUISITION CORPORATION II	+1.68%	663M
E7 GROUP	+0.54%	610M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ALTC ACQUISITION CORP.	+21.31%	552M